ABC's bioanalytical team has developed and validated over 150 proprietary methods for preclinical and clinical programs, and has experience with 25 drug classes and across every biological matrix. Our approach to method development combines ingenuity with proven scientific practice, applying extensive experience in HPLC-UV, LC-MS/MS, as well as ELISA and RIA techniques to deliver sensitive methods with the lower limit of quantitation (LLOQ).
When you visit ABC Laboratories, you will find a modern, GLP-compliant facility and Standard Operating Procedures that strictly adhere to current FDA guidance. Our scientists and QA professionals work according to well-defined business processes that promote continuous quality improvement, timely delivery and transparent communication.